Abstract
The Centers for Medicare & Medicaid Services has issued a final rule requiring prescription drug plans in Medicare Part D to include, in their published drug prices, the expected value of all fees deducted from pharmacy reimbursement. These are the direct and indirect remuneration fees about which there has been such long-standing argument. What is the effect of this final rule?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
